pneumococcal protein vaccine

Vaccineexperimental

Clinical trial activity

6 trials · 13 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Aug 31, 2004 (NCT00142389)

Timeline

2000s

  1. Jan 1, 2004

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2018

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • pneumococcal protein vaccine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03514979Phase 2Jun 30, 2018University of Cambridge, Versus Arthritis
NCT01446926Phase 1Sep 30, 2011Sanofi-Aventis
NCT01764126Phase 1Sep 1, 2011International Center for Diarrheal Disease Research, Sanofi-Aventis
NCT01444339Phase 1Feb 28, 2010Sanofi, Sanofi-Aventis
NCT00099658N/AApr 30, 2005Cipra, National Institute of Allergy and Infectious Diseases (NIAID), University of the Witwatersrand
NCT00142389Phase 1/Phase 2 (Phase 2)Aug 31, 2004Bill and Melinda Gates Foundation, International Center for Diarrheal Disease Research, Johns Hopkins University, Pfizer, Thrasher Research Fund, United States Agency for International Development
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (13)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Sanofi-AventisFor profit3112010
International Center for Diarrheal Disease ResearchAcademic/Hospital2122004
Bill and Melinda Gates FoundationAcademic/Hospital1012004
CipraAcademic/Hospital1112005
Johns Hopkins UniversityAcademic/Hospital1112004
National Institute of Allergy and Infectious Diseases (NIAID)Government1012005
PfizerFor profit1012004
SanofiFor profit1112010
Thrasher Research FundAcademic/Hospital1012004
United States Agency for International DevelopmentGovernment1012004
University of CambridgeAcademic/Hospital1112018
University of the WitwatersrandAcademic/Hospital1012005
Versus ArthritisAcademic/Hospital1012018
13 organizations
Page 1 / 1